Javascript must be enabled to continue!
Ablation index-guided ablation with milder targets for atrial fibrillation: Comparison between high power and low power ablation
View through CrossRef
BackgroundHigh power-ablation index (HP-AI)-guided ablation for atrial fibrillation (AF) targeting high AIs has been implemented in European countries. However, milder AI targets are widely used in Asia. The safety and efficacy of HP-AI-guided ablation compared with those of low-power AI-guided ablation in a milder AI-targeting setting are unknown. The goal of this study was to explore the efficacy and safety of HP-AI-guided ablation in a milder AI-targeting setting.MethodsPatients who underwent pulmonary vein isolation (PVI) for AI-guided atrial fibrillation ablation in our center were enrolled and divided into 2 groups according to the ablation power used. In the HP-AI group, the ablation power was over 45 W, while the low power-AI group was ablated with <35 W power. The targeted AIs were 450–500 in the anterior wall and 350–400 in the posterior wall. The efficacy outcome was expressed as the single-procedure atrial arrhythmia-free survival between 91 days and 1 year. Safety outcomes included severe adverse events (SAEs), including symptomatic pulmonary vein (PV) stenosis, atrioesophagal fistula, cardiac tamponade, stroke, thromboembolism events, myocardial infarction, and major bleeding.ResultsA total of 134 patients were enrolled, of whom 74 underwent PVI using HP-AI, while 60 received low power-AI ablation. After a mean follow-up time of 7.4 months, 22 (16.4%) patients showed arrhythmia recurrence: 5 (6.8%) patients in the HP-AI group and 17 (28.3%) patients in the low power-AI group. The HP-AI group showed a significantly higher arrhythmia-free survival than the low power-AI group (p = 0.011). Two patients in the low power-AI group and 1 patient in the HP-AI group developed an SAE (p = NS). Compared with the low power-AI group, the HP-AI group demonstrated a higher PV first-pass isolation rate, shorter ablation time, and fewer patients with anatomical leakages and sites of unreached AI.ConclusionIn a milder AI setting, HP-AI ablation might result in significantly higher arrhythmia-free survival than low power-AI ablation and a similar safety profile.
Title: Ablation index-guided ablation with milder targets for atrial fibrillation: Comparison between high power and low power ablation
Description:
BackgroundHigh power-ablation index (HP-AI)-guided ablation for atrial fibrillation (AF) targeting high AIs has been implemented in European countries.
However, milder AI targets are widely used in Asia.
The safety and efficacy of HP-AI-guided ablation compared with those of low-power AI-guided ablation in a milder AI-targeting setting are unknown.
The goal of this study was to explore the efficacy and safety of HP-AI-guided ablation in a milder AI-targeting setting.
MethodsPatients who underwent pulmonary vein isolation (PVI) for AI-guided atrial fibrillation ablation in our center were enrolled and divided into 2 groups according to the ablation power used.
In the HP-AI group, the ablation power was over 45 W, while the low power-AI group was ablated with <35 W power.
The targeted AIs were 450–500 in the anterior wall and 350–400 in the posterior wall.
The efficacy outcome was expressed as the single-procedure atrial arrhythmia-free survival between 91 days and 1 year.
Safety outcomes included severe adverse events (SAEs), including symptomatic pulmonary vein (PV) stenosis, atrioesophagal fistula, cardiac tamponade, stroke, thromboembolism events, myocardial infarction, and major bleeding.
ResultsA total of 134 patients were enrolled, of whom 74 underwent PVI using HP-AI, while 60 received low power-AI ablation.
After a mean follow-up time of 7.
4 months, 22 (16.
4%) patients showed arrhythmia recurrence: 5 (6.
8%) patients in the HP-AI group and 17 (28.
3%) patients in the low power-AI group.
The HP-AI group showed a significantly higher arrhythmia-free survival than the low power-AI group (p = 0.
011).
Two patients in the low power-AI group and 1 patient in the HP-AI group developed an SAE (p = NS).
Compared with the low power-AI group, the HP-AI group demonstrated a higher PV first-pass isolation rate, shorter ablation time, and fewer patients with anatomical leakages and sites of unreached AI.
ConclusionIn a milder AI setting, HP-AI ablation might result in significantly higher arrhythmia-free survival than low power-AI ablation and a similar safety profile.
Related Results
Adiponectin and Lone atrial fibrillation
Adiponectin and Lone atrial fibrillation
Objective: Lone atrial fibrillation is an idiopathic arrhythmia seen in younger individuals without any secondary disease. Adiponectin is an endogenous adipocytokine that increases...
RELATIONSHIP BETWEEN ATRIAL FIBRILLATION CARDIOVERSION AND F
RELATIONSHIP BETWEEN ATRIAL FIBRILLATION CARDIOVERSION AND F
Objectives
To investigate the relationship between atrial fibrillation cardioversion and f wave in electrocardiogram, providing an ordinary and noninvasive method...
ASSA13-03-9 Decreased Expression of Small-Conductance Ca2+-Activated K+ Channels SK1, SK2, and SK3 in Patients with Persistent Atrial Fibrillation
ASSA13-03-9 Decreased Expression of Small-Conductance Ca2+-Activated K+ Channels SK1, SK2, and SK3 in Patients with Persistent Atrial Fibrillation
Background
Small-conductance Ca2+-activated K+ channels (SK channels) have been reported involved in atrial fibrillation (AF) as a new ion channel candidates, as ...
Catheter ablation as a potential treatment alternative for atrial fibrillation among patients with heart failure with preserved ejection fraction: a retrospective cohort study
Catheter ablation as a potential treatment alternative for atrial fibrillation among patients with heart failure with preserved ejection fraction: a retrospective cohort study
Abstract
Background
In patients with heart failure with reduced ejection fraction, catheter ablation for atrial fibrillation is a useful alternative to drug-induced rhythm...
Diagnostic accuracy of an oscillometric blood pressure monitor for atrial fibrillation screening
Diagnostic accuracy of an oscillometric blood pressure monitor for atrial fibrillation screening
Objective
Atrial fibrillation is the most common arrhythmia of clinical significance and hypertension is one of its major risk factors. This study aimed to evaluate the...
Left atrial function assessment by speckle tracking echocardiography in low-risk atrial fibrillation patients
Left atrial function assessment by speckle tracking echocardiography in low-risk atrial fibrillation patients
Objective: To compare the left atrial function utilising speckle tracking echocardiography in patients with low-risk and high-risk non-valvular atrial fibrillation.Methods: The des...
REMODELLING OF CONNEXIN 43 IN ATRIAL MYOCARDIUM OF PATIENTS WITH ATRIAL FIBRILLATION
REMODELLING OF CONNEXIN 43 IN ATRIAL MYOCARDIUM OF PATIENTS WITH ATRIAL FIBRILLATION
Objectives
Remodelling of connexins was found accompanying with atrial fibrillation. The aim of the study is to investigate whether it is the remodelling of conne...
Long term success of cavotricuspid isthmus ablation guided by the ablation index: results of the FLAI registry
Long term success of cavotricuspid isthmus ablation guided by the ablation index: results of the FLAI registry
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
...

